Imunon, Inc. (IMNN) Estados Financieros e Histórico

Imunon, Inc. (IMNN) — Precio $1.41 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Imunon, Inc. (IMNN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.

Al precio actual de $1.41, IMNN presenta beneficios negativos (P/E no significativo) y un ROE del -314.89%. La capitalización bursátil es de $6M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$500000$500000$500000$500000$500000$500000$500000000
Coste de Ventas0000000000
Beneficio Bruto$500000$500000$500000$500000$500000$500000$500000000
I+D$14.6M$13.1M$11.9M$13.1M$11.3M$10.6M$11.7M$11.3M$11.6M$7.8M
Generales y Administrativos$6.5M$5.9M$9.7M$8.0M$7.6M$10.9M$13.7M$9.7M$7.5M$6.9M
Gastos Operativos$21.1M$19.0M$21.6M$21.1M$19.0M$21.5M$25.4M$21.0M$19.1M$14.7M
Beneficio Operativo-$20.6M-$18.5M-$21.1M-$20.6M-$18.5M-$21.0M-$24.9M-$21.0M-$19.1M-$14.7M
EBITDA-$20.3M-$19.8M-$21.2M-$16.6M-$21.3M-$20.9M-$31.7M-$19.9M-$17.9M-$13.8M
Gastos por Intereses$722993$91756$712025$1.4M$1.3M$569881$5.0M$19708000
Beneficio Antes de Impuestos-$22.1M-$20.4M-$22.3M-$18.7M-$23.3M-$22.2M-$37.5M-$20.8M-$18.6M-$14.5M
Impuestos00-$10.4M-$1.8M-$1.8M-$1.4M-$1.6M-$1.3M00
Beneficio Neto-$22.1M-$20.4M-$11.9M-$16.9M-$21.5M-$20.8M-$35.9M-$19.5M-$18.6M-$14.5M
BPA$-2328.26$-532.22$-132.23$-151.01$-131.51$-748.77$-65.55$-28.14$-21.10$-6.83
BPA Diluido$-2328.26$-532.22$-132.23$-151.01$-131.51$-748.77$-65.55$-28.14$-21.10$-6.83
Acciones en Circulación (Diluidas)$9476$38983$89868$111590$163357$27737$547627$693474$882292$2.1M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos0000
Beneficio Bruto00-$1665440
Beneficio Operativo-$3.5M-$4.3M-$4.3M-$2.8M
EBITDA-$3.3M-$4.1M-$4.1M-$2.7M
Beneficio Neto-$3.4M-$4.2M-$4.2M-$2.8M
BPA$-1.16$-1.99$-0.84$-0.54
BPA Diluido$-1.16$-1.99$-0.84$-0.54

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$2.6M$11.4M$13.4M$6.9M$17.2M$19.6M$11.5M$5.8M$5.9M$8.8M
Inversiones a Corto$1.7M$12.7M$14.3M$8.0M0$29.8M$21.3M$9.9M00
Cuentas por Cobrar$4008$54440$68309$213690$108844$128932000
Inventario0000000000
Activos Corrientes$4.5M$24.3M$28.1M$16.2M$18.8M$51.9M$36.8M$18.2M$8.0M$10.7M
Inmovilizado Material$462836$175771$184627$1.8M$1.3M$1.2M$704177$2.3M$1.7M$1.6M
Fondo de Comercio$2.0M$2.0M$2.0M$2.0M$2.0M00000
Activos Intangibles$23.8M$21.0M$16.3M$16.1M$13.5M$13.4M0000
Activos Totales$30.8M$47.5M$46.9M$38.3M$37.5M$74.0M$44.0M$21.9M$9.7M$12.3M
Cuentas por Pagar$2.9M$3.4M$3.0M$2.9M$2.2M$2.5M$3.6M$3.5M$1.3M$1.4M
Deuda a Corto$2.6M00$1.8M$1.1M0$1.4M000
Pasivos Corrientes$8.4M$6.2M$6.1M$7.9M$6.8M$6.8M$10.0M$7.4M$4.8M$4.6M
Deuda a Largo00$9.4M$8.0M$3.9M$5.9M$4.6M00$602000
Pasivos Totales$24.1M$20.8M$26.0M$23.7M$18.9M$18.3M$14.6M$8.5M$5.5M$5.2M
Reservas-$241.4M-$261.8M-$273.7M-$290.5M-$312.0M-$332.8M-$368.7M-$388.2M-$406.8M-$421.3M
Patrimonio Neto$6.7M$26.7M$20.9M$14.6M$18.6M$55.8M$29.3M$13.4M$4.2M$7.1M
Deuda Total$2.6M0$9.4M$11.3M$6.2M$6.6M$6.3M$1.6M$1.1M$1.0M
Deuda Neta-$1.7M-$24.2M-$18.2M-$3.5M-$11.0M-$42.8M-$26.5M-$14.1M-$4.7M-$7.8M
Capital Circulante-$3.9M$18.1M$22.0M$8.3M$12.1M$45.2M$26.7M$10.8M$3.2M$6.1M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$5.3M$8.8M$4.8M$6.9M
Activos Totales$9.0M$12.3M$8.0M$15.0M
Pasivos Totales$4.9M$5.2M$4.7M$10.8M
Patrimonio Neto$4.1M$7.1M$3.4M$4.2M
Deuda Total$1.1M$1.0M$911752$7.8M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$22.1M-$20.4M-$11.9M-$16.9M-$21.5M-$20.8M-$35.9M-$19.5M-$18.6M-$14.5M
Amortizaciones$1.0M$553010$356859$721665$741524$702918$731629$720005$718116$698900
Compensación en Acciones$1.5M$1.1M$4.6M$2.3M$1.9M$3.8M$2.7M$759013$477256$127374
Cambio en Capital Circulante$120604-$98254-$1.2M-$2.2M-$864360-$970744$1.9M-$2.1M-$2.6M-$327614
Flujo de Caja Operativo-$18.4M-$16.6M-$7.0M-$20.3M-$15.6M-$16.2M-$23.1M-$19.0M-$18.9M-$13.9M
Inversiones (CapEx)-$62503-$38629-$138399-$349158-$19092-$311613-$267800-$451759-$29541-$280572
Adquisiciones0000000000
Recompra de Acciones0000000000
Dividendos Pagados000000000-$10277
Flujo de Caja Libre-$18.4M-$16.7M-$7.2M-$20.6M-$15.6M-$16.5M-$23.4M-$19.5M-$18.9M-$14.2M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$4.4M-$3.7M-$4.0M-$3.99B
Inversiones (CapEx)$3-$3589-$4-$69.1M
Flujo de Caja Libre-$4.4M-$3.7M-$4.0M-$4.06B
Dividendos Pagados0000
Compensación en Acciones0$114790$93.3M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%-100.0%
Crecimiento Beneficio Neto (anual)+7.5%+41.8%-41.8%-27.5%+3.3%-72.8%+45.6%+4.6%+22.2%
Crecimiento BPA (anual)+77.1%+75.2%-14.2%+12.9%-469.4%+91.2%+57.1%+25.0%+67.6%
Cambio en Acciones (anual)+311.4%+130.5%+24.2%+46.4%-83.0%+1874.4%+26.6%+27.2%+140.6%
Crecimiento FCF (anual)+9.5%+57.0%-187.0%+24.1%-5.7%-41.3%+16.7%+3.0%+24.9%
Margen Bruto100.0%100.0%100.0%100.0%100.0%100.0%100.0%
Margen Operativo-4130.0%-3693.7%-4213.0%-4113.1%-3697.3%-4201.4%-4984.3%
Margen EBITDA-4061.6%-3951.5%-4246.7%-3310.6%-4259.1%-4176.0%-6341.0%
Margen Neto-4410.7%-4080.4%-2376.7%-3370.3%-4296.7%-4153.9%-7179.6%
Margen FCF-3688.4%-3336.1%-1436.0%-4121.6%-3127.6%-3307.0%-4672.9%
Tasa Impositiva Efectiva-0.0%-0.0%46.7%9.7%7.9%6.2%4.2%6.2%-0.0%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-1946.17$-427.90$-79.90$-184.68$-95.73$-596.14$-42.67$-28.08$-21.40$-6.68
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$9476$38983$89868$111590$163357$27737$547627$693474$882292$2.1M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-314.89%
Rentabilidad sobre capital invertido-122.18%
Rentabilidad sobre activos-98.17%
Margen bruto0.00%
Margen operativo0.00%
Margen neto0.00%

Salud financiera

Deuda / Patrimonio1.87
Ratio corriente1.82

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-0.41-1.19-2.40-2.55-1.21-0.16-0.31-0.36-0.68-0.56
P/VC1.330.931.372.951.400.060.380.532.961.15
P/V17.9149.4757.0285.8752.196.7422.180.000.000.00
Margen Bruto100.0%100.0%100.0%100.0%100.0%100.0%100.0%0.0%0.0%0.0%
Margen Operativo-4130.0%-3693.7%-4213.0%-4113.1%-3697.3%-4201.4%-4984.3%0.0%0.0%0.0%
Margen Neto-4410.7%-4080.4%-2376.7%-3370.3%-4296.7%-4153.9%-7179.6%0.0%0.0%0.0%

Empresas relacionadas: AEON · BOLT · CING · CLRB · COCP · DWTX · EVGN

Explorar sector: Healthcare · Biotechnology

Más secciones de IMNN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones